Anti-KIT Neutralizing Antibody (V3S-0622-YC4871) (CAT#: V3S-0622-YC4871)

Send Inquiry
  • fig1
    Figure 1 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in DB
  • fig1
    Figure 2 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in WB
  • fig1
    Figure 3 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in ELISA
  • fig1
    Figure 4 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SDS-PAGE.
  • fig1
    Figure 5 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SEC-HPLC.
  • fig1
    Figure 6 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in WB.
  • fig1
    Figure 7 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in DB.
  • fig1
    Figure 8 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in ELISA.

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with KIT. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; WB; DB; FuncS
Application Notes The antibody is recommended for detection of KIT by FuncS assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target KIT
Alternative Name KIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; PBT; SCFR; C-Kit; CD117; mast/stem cell growth factor receptor Kit; p145 c-kit; proto-oncogene c-Kit; piebald trait protein; soluble KIT variant 1; tyrosine-protein kinase Kit; proto-onco
Gene ID 3815
UniProt A0A024RDA0
Research Area Cancer Research

Tested Data

DB

Figure 1 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in DB

Dot Blot analysis of V3S-0622-YC4871 was performed by coating with c-Kit Protein, Human, Recombinant (His Tag).
The secondary antibody: HRP Goat Anti-Human IgG (H+L)

Figure 1 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in DB

WB

Figure 2 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in WB

Western blot analysis of V3S-0622-YC4871 was performed by loading c-Kit Protein, Human, Recombinant (His Tag).
The secondary antibody: HRP Goat Anti-Human IgG (H+L)

Lane 1: Reducing antigen (0.1 μg)
Lane 2: Reducing antigen (0.3 μg)
Lane 3: Reducing antigen (0.6 μg)

Figure 2 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in WB

ELISA

Figure 3 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in ELISA

ELISA analysis of V3S-0622-YC4871 was performed by coating with c-Kit Protein, Human, Recombinant (His Tag).
The secondary antibody: HRP Goat Anti-Human IgG (H+L)

Figure 3 Anti-Human KIT Monoclonal Antibody (V3S-0622-YC4871) in ELISA

SDS-PAGE

Figure 4 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SDS-PAGE.

SDS-PAGE analysis of V3S-0622-YC4871 in β-mercaptoethanol-reduced conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.

Figure 4 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SDS-PAGE.

SEC-HPLC

Figure 5 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SEC-HPLC.

The purity of V3S-0622-YC4871 was greater than 95% as determined by SEC-HPLC.

Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.0
Detection: UV 280 nm
Injection: 10 µl

Figure 5 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in SEC-HPLC.

WB

Figure 6 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in WB.

Western blot analysis was performed by loading 0.1 µg (lane 1), 0.3 µg(lane 2), and 0.6 µg (lane 3) recombinant human KIT onto a 12% Tris-HCl polyacrylamide gel.

Figure 6 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in WB.

DB

Figure 7 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in DB.

Dot Blot analysis of V3S-0622-YC4871 was performed by coating with human KIT antigen.

Figure 7 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in DB.

ELISA

Figure 8 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in ELISA.

ELISA analysis of V3S-0622-YC4871 was performed by coating with c-Kit Protein, Human, Recombinant (ECD, His Tag).

Figure 8 Anti-KIT Monoclonal Antibody (V3S-0622-YC4871, Lot#CB2303LX10) in ELISA.

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry